Results 181 to 190 of about 19,930 (199)

Therapeutic Options for Metallo-β-Lactamase-Producing Enterobacterales

Infection and Drug Resistance, 2021
Kimberly Baugh, Yanqin Huang, Neeraja Kadiyala   +2 more
exaly  

Alcaligenes faecalis metallo-β-lactamase in extensively drug-resistant Pseudomonas aeruginosa isolates

Clinical Microbiology and Infection, 2022
Yue Li, Yiwei Zhu, Yu Feng
exaly  

Discovery of thiosemicarbazone derivatives as effective New Delhi metallo-β-lactamase-1 (NDM-1) inhibitors against NDM-1 producing clinical isolates

Acta Pharmaceutica Sinica B, 2021
Bing Zhao, Xinhui Zhang, Ying Liu
exaly  

The urgent need for metallo-β-lactamase inhibitors: an unattended global threat

Lancet Infectious Diseases, The, 2022
Maria F Mojica, Maria-Agustina Rossi, Alejandro J Vila   +2 more
exaly  

Novel metallo-β-lactamase inhibitors

Nature Reviews Microbiology, 2021
exaly  

New Delhi Metallo-Beta-Lactamase Facilitates the Emergence of Cefiderocol Resistance in Enterobacter cloacae

Antimicrobial Agents and Chemotherapy, 2022
Dennis Nurjadi, Ali Kaan Kocer, Sabrina Klein   +2 more
exaly  

The Continuing Challenge of Metallo-β-Lactamase Inhibition: Mechanism Matters

Trends in Pharmacological Sciences, 2018
Zishuo Cheng, Walter Fast, Michael W Crowder   +2 more
exaly  

Cross-class metallo-β-lactamase inhibition by bisthiazolidines reveals multiple binding modes

Proceedings of the National Academy of Sciences of the United States of America, 2016
Philip Hinchliffe, Maria F Mojica, Javier M Gonzalez   +2 more
exaly